Across TCGA pan-cancer cohorts, CYP4F27P RNA is linked to patient survival in 19 of 34 cancer types, making it the most broadly survival-associated CYP4F27P data layer.
The strongest signal is observed in uveal melanoma (UVM), where higher CYP4F27P RNA is associated with worse overall survival. In most high-consensus cancer types, elevated CYP4F27P expression acts as an unfavorable survival marker, although some lineages such as PAAD and UCEC show a favorable association.
UVM, THCA, and DLBC are the cancer types where CYP4F27P RNA most reproducibly stratifies survival.
RNA survival associations by lineage
Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.